The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Boston Scientific Corp. (NYSE:BSX) is one of the 12 best buy-the-dip stocks to invest in now.

On June 4, Truist significantly decreased the price target on Boston Scientific Corp. (NYSE:BSX), from $85 to $64, while maintaining a Buy rating on the stock. The firm cited recent management remarks indicating that the Watchman device’s growth in the U.S. market was slowing.

VILevi/Shutterstock.com

Truist believes that Boston Scientific’s current valuation is still quite distant from its strong underlying financials in spite of these particular product challenges. According to Truist, the company is still projecting a strong financial profile, with a double-digit increase in EPS and at least 7% growth in top-line revenue.

Back on May 28, Goldman Sachs decreased the target price on Boston Scientific Corp. (NYSE:BSX) from $81 to $71. The firm maintained its Buy rating on the shares, which still offer an adjusted upside potential in excess of 45%.

Goldman Sachs also reflected on the management’s views around Watchman revenue expectations for the second and third quarters. This formed the basis for the firm’s current stance on the company.

Boston Scientific Corp. (NYSE:BSX) specializes in medical devices for interventional specialties such as cardiovascular, endo-surgery, and neuro-modulation. The company operates through MedSurg and Cardiovascular segments, and offers a range of devices, including biliary stent systems, electrocautery enhanced delivery systems, direct visualization systems, and single-use duodeno-scopes.

While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.